Submitted by Anonymous (not verified) on 1 September 2026 - 11:30
Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised